Patient Pathfinder: Clinical Trials
Clinical Trials for Ovarian Cancer
Every life-saving or life-extending treatment that’s available today for cancer started its journey in a clinical trial. A clinical trial is a study that helps doctors better understand cancer, and discover safer and more effective ways to treat it.
Clinical trials also give patients a chance to try a treatment before it’s approved by the U.S. Food and Drug Administration.
There are 440 active Ovarian Cancer trials
Abemaciclib and Letrozole in Treating Patients With Endometrial Cancer
Study Type: Interventional Early Phase 1
Ovarian Dendritic Cell Vaccine Trial
Study Type: Interventional Phase 2
Study of Olaparib Maintenance Following Cabazitaxel-Carbo in Men With AVPC
Study Type: Interventional Phase 2
Phase II High Risk Prostate Cancer Trial Using Gene & Androgen Deprivation Therapies, Radiotherapy, & Surgery
Study Type: Interventional Phase 2
ENB003 Plus Pembrolizumab Phase 1b/2a in Solid Tumors
Study Type: Interventional Phase 1
A Study of Pembrolizumab on the Tumoral Immunoprofile of Gynecologic Cancers
Study Type: Interventional Early Phase 1
Testing Whether the Combination of Two Immunotherapy Drugs Have Activity in Recurrent or Persistent Clear Cell Ovarian Cancer
Study Type: Interventional Phase 2
Trial on Radical Upfront Surgery in Advanced Ovarian Cancer
Study Type: Interventional
There are 440 active Ovarian Cancer trials
Filter Results
Phase
Study Type
Need more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start NowNeed more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start Now